WHO世界卫生组织：2025年世卫组织东南亚区域最高零售定价政策报告（英文版）

Essential medicines must meet the priority health-care needs of the population and are chosen based on public health relevance, efficacy and safety evidence, and cost-effectiveness.(1) Access to essential medicines is crucial in the WHO South-East Asia Region, where low public health spending leads to high out-of-pocket expenses for medicines.(2, 3) This financial burden pushes millions into poverty, stressing the urgent need for affordable medical products in the Region.(2) The ministries of